A high-throughput, low-cost genotyping platform using SNP and SSR molecular markers linked to 18 apple scab resistance genes to enable marker-assisted selection (MAS) in INIA-Chile's apple breeding program. The platform aims to increase selection efficiency, reduce phenotyping costs, and accelerate development of scab-resistant apple cultivars.
Apple scab, caused by Venturia inaequalis, is the most significant disease affecting apple production in Chile and other temperate regions worldwide. INIA-Chile's apple breeding program (ABP) develops approximately 4,000 segregants annually, aiming to produce new cultivars with genetic resistance to scab. Currently, seedling-stage inoculation eliminates only 25% of segregants, while at least 50% of sensitive genotypes are expected in F1 progenies. After seven years and substantial investment in nursery, grafting, and planting phases, only 0 to 3 genetic lines from 2,500 advanced segregants are typically selected as potential cultivars. This proposal addresses the urgent need to improve early-stage selection efficiency and reduce the costs associated with phenotyping sensitive genotypes.
The proposed solution is a high-throughput, low-cost genotyping platform based on molecular markers linked to apple scab resistance genes. By implementing a marker-assisted selection (MAS) strategy, the platform will enable earlier and more accurate identification of resistant genotypes, significantly reducing the time, labor, and cost required to develop new scab-resistant apple cultivars.
The platform is currently at the development and validation stage. The molecular markers linked to 18 scab resistance genes have been identified and compiled from existing scientific literature. The next phase involves genotyping the founding population and 10 scab resistance lines to characterize the scab resistance genes present, followed by designing a MAS strategy based on a cost-benefit analysis. Validation will focus on demonstrating that MAS increases selection efficiency and reduces costs compared to the current phenotyping-based approach. The platform is intended for integration into the operational workflow of INIA-Chile's apple breeding program, with potential scalability to other breeding programs targeting apple scab resistance.
INIA is Chile’s national agricultural research and innovation institute, a private non‑profit corporation linked to the Ministry of Agriculture, with roughly 1,000 staff and a network of 11 regional research centers across the country. Co‑located experimental farms and specialized laboratory services enable field‑to‑lab collaboration for partners. A national germplasm bank network and an International Depository Authority microbial collection support characterization, secure deposits, and downstream commercialization. Core funding comes via a performance agreement with the Undersecretariat of Agriculture, complemented by competitive national R&D and innovation programs and revenue from services, seeds, and varieties. Dedicated extension and technology transfer programs accelerate adoption through demonstrations, training, and variety release to producers and agri‑food firms.